PharmaAudioconference: Home

The National Congress on the Future of Pharmaceuticals in Medical Care

An Analysis of the New OIG Model Compliance Guidance for the Pharmaceutical Industry

Sponsored by
Pharmaceutical Compliance Forum

Supported by
PricewaterhouseCooper

Tuesday, October 22, 2002

7:00 am - 8:30 am H/AST (Hawaii-Aleutian)
9:00 am - 10:30 am ADT (Alaska)
10:00 am-11:30 am PDT (and Arizona)
11:00 am-12:30 pm MDT
12:00 pm-1:30 pm CDT
1:00 pm-2:30 pm EDT

For future information about The National Congress on the Future of Genomics, Biotechnology and Pharmaceuticals Conference Series, please complete the form below.

First Name:

Last Name:

Email:

Featured Faculty
Douglas Lankler, Esq. Senior Corporate Counsel And Deputy Corporate Compliance Officer Pfizer, Inc. New York, NY Bert Weinsein, Esq. Vice President and Assistant General Counsel Merck & Co. Whitehouse Station, NJ Michael Swiatocha Director, PricewaterhouseCoopers Florham Park, NJ

SAVE THE FOLLOWING DATES: